CPhI: Aesica to triple API sales in three years, to acquire assets in North America and India next year

14:18 PM | October 11, 2012 | Deepti Ramesh in Madrid

Aesica Pharmaceuticals (Newcastle, UK), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says that it plans to triple annual revenues from the company’s API...